Overall, there are high rates of heart failure medication usage at the time of enrollment with 90% of individuals taking β‐blockers and 88% taking angiotensin‐converting enzyme inhibitors (ACE‐Is) or angiotensin receptor blockers. Here, ACE is linked to heart failure.